ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.742,22
-0,08%
S&P 500
5.221,42
-0,02%
Dow Jones
39.431,51
-0,21%
Euro vs US Dollar
1,07885
0,17%
Bitcoin
63.148,14
2,77%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Journey Medical Corporation (DERM)

  7. Journey Medical Corporation (DERM) News

DERM

Journey Medical (DERM)

Journey Medical Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:DERM
DatumZeitQuelleÜberschriftSymbolFirma
13/05/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
13/05/202422h01GlobeNewswire Inc.Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:DERMJourney Medical Corporation
07/05/202414h30GlobeNewswire Inc.Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024NASDAQ:DERMJourney Medical Corporation
01/05/202422h01GlobeNewswire Inc.Journey Medical Corporation Appoints Joseph Benesch as Chief Financial OfficerNASDAQ:DERMJourney Medical Corporation
25/04/202414h30GlobeNewswire Inc.Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024NASDAQ:DERMJourney Medical Corporation
21/03/202421h01GlobeNewswire Inc.Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate HighlightsNASDAQ:DERMJourney Medical Corporation
18/03/202413h30GlobeNewswire Inc.Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of RosaceaNASDAQ:DERMJourney Medical Corporation
15/03/202413h30GlobeNewswire Inc.Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024NASDAQ:DERMJourney Medical Corporation
13/03/202413h30GlobeNewswire Inc.Journey Medical Corporation to Participate in the 36th Annual ROTH ConferenceNASDAQ:DERMJourney Medical Corporation
11/03/202413h30GlobeNewswire Inc.Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual MeetingNASDAQ:DERMJourney Medical Corporation
23/02/202423h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DERMJourney Medical Corporation
05/01/202414h30GlobeNewswire Inc.Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat RosaceaNASDAQ:DERMJourney Medical Corporation
02/01/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
02/01/202422h05GlobeNewswire Inc.Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 MillionNASDAQ:DERMJourney Medical Corporation
15/12/202322h46Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DERMJourney Medical Corporation
08/12/202323h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
06/12/202314h00GlobeNewswire Inc.Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat RosaceaNASDAQ:DERMJourney Medical Corporation
07/11/202322h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
07/11/202322h01GlobeNewswire Inc.Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate HighlightsNASDAQ:DERMJourney Medical Corporation
31/10/202313h30GlobeNewswire Inc.Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:DERMJourney Medical Corporation
20/10/202314h30GlobeNewswire Inc.Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) vs. Solodyn® (Minocycline Hydrochloride Extended-Release Tablets, 105 mg)NASDAQ:DERMJourney Medical Corporation
17/10/202322h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DERMJourney Medical Corporation
26/09/202315h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
19/09/202322h59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
08/09/202319h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DERMJourney Medical Corporation
06/09/202314h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
06/09/202314h00GlobeNewswire Inc.Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbrexza® in South Korea and Other Asian NationsNASDAQ:DERMJourney Medical Corporation
18/08/202323h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
14/08/202322h01GlobeNewswire Inc.Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate HighlightsNASDAQ:DERMJourney Medical Corporation
10/08/202322h45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DERMJourney Medical Corporation
 Showing the most relevant articles for your search:NASDAQ:DERM

Kürzlich von Ihnen besucht

TG
MBG
MercedesBenz
NYSE
XOM
Exxon Mobil
CCOM
US500
US 500
NYSE
NKE
Nike
FX
EURUSD
Euro vs US Dollar
FX
EURJPY
Euro vs Yen
USOTC
ADDYY
Adidas (QX)
USOTC
BASFY
BASF (QX)
COIN
SOLUSD
Solana
NYSE
JPM
JP Morgan Chase
NASDAQ
AMZN
Amazon.com
AMEX
XLV
Health Care Select Sector
FX
EURGBP
Euro vs Sterling
TG
BAYN
Bayer
NASDAQ
TSLA
Tesla
TG
DBK
Deutsche Bank
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten